Cellular and molecular mechanisms of chikungunya pathogenesis

Antiviral Research

Volumn 120, Issue , 2015, Pages 165-174

  Lum, Fok Moon ^a,b   Ng, Lisa F P ^a,b,c  

^a AGENCY FOR SCIENCE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Chikungunya virus; Immune response; Immunopathogenesis; Pathology

Indexed keywords

INTERFERON; INTERLEUKIN 6;

APOPTOSIS; ARTHRALGIA; ARTICLE; AUTOPHAGY; B LYMPHOCYTE; CHIKUNGUNYA; CHIKUNGUNYA VIRUS; CYTOKINE PRODUCTION; DENDRITIC CELL; FEVER; HUMAN; IMMUNOPATHOGENESIS; NATURAL KILLER CELL; NONHUMAN; OSTEOCLASTOGENESIS; PATHOGENESIS; PRIORITY JOURNAL; RASH; T LYMPHOCYTE; VIRUS REPLICATION; HOST PATHOGEN INTERACTION; HUMORAL IMMUNITY; IMMUNOLOGY; INNATE IMMUNITY; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; VIROLOGY;

ARBOVIRUS; CHIKUNGUNYA VIRUS;

CHIKUNGUNYA FEVER; CHIKUNGUNYA VIRUS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, HUMORAL; IMMUNITY, INNATE;

EID: 84932621645     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2015.06.009     Document Type: Review

References (135)

1. W. Akahata, Z.Y. Yang, H. Andersen, S. Sun, H.A. Holdaway, W.P. Kong, M.G. Lewis, S. Higgs, M.G. Rossmann, S. Rao, and G.J. Nabel A virus-like particle vaccine for epidemic chikungunya virus protects nonhuman primates against infection Nat. Med. 16 3 2010 334 338
2. M. Alvarez, R. Rodriguez-Roche, L. Bernardo, S. Vazquez, L. Morier, D. Gonzalez, O. Castro, G. Kouri, S.B. Halstead, and M.G. Guzman Dengue hemorrhagic fever caused by sequential dengue 1-3 virus infections over a long time interval: Havana epidemic, 2001-2002 Am. J. Trop. Med. Hyg. 75 6 2006 1113 1117
3. S.J. Balsitis, K.L. Williams, R. Lachica, D. Flores, J.L. Kyle, E. Mehlhop, S. Johnson, M.S. Diamond, P.R. Beatty, and E. Harris Lethal antibody enhancement of dengue disease in mice is prevented by fc modification PLoS Pathog. 6 2 2010 e1000790
4. E.E. Bates, N. Fournier, E. Garcia, J. Valladeau, I. Durand, J.J. Pin, S.M. Zurawski, S. Patel, J.S. Abrams, and S. Lebecque APCS express DCIR, a novel c-type lectin surface receptor containing an immunoreceptor tyrosine-based inhibitory motif J. Immunol. 163 4 1999 1973 1983
5. Y. Belkaid Regulatory t cells and infection: a dangerous necessity Nat. Rev. Immunol. 7 11 2007 875 888
6. Y. Belkaid, and B.T. Rouse Natural regulatory t cells in infectious disease Nat. Immunol. 6 4 2005 353 360
7. M. Bhatia, R.D. Ramnath, L. Chevali, and A. Guglielmotti Treatment with Bindarit, a blocker of mcp-1 synthesis, protects mice against acute pancreatitis Am. J. Physiol. Gastrointest. Liver Physiol. 288 6 2005 G1259 G1265
8. G. Borgherini, P. Poubeau, F. Staikowsky, M. Lory, N. le Moullec, J.P. Becquart, C. Wengling, A. Michault, and F. Paganin Outbreak of chikungunya on reunion island: early clinical and laboratory features in 157 adult patients Clin. Infect. Dis. 44 11 2007 1401 1407
9. S. Brandler, C. Ruffie, C. Combredet, J.B. Brault, V. Najburg, M.C. Prevost, A. Habel, E. Tauber, P. Despres, and F. Tangy A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus Vaccine 31 36 2013 3718 3725
10. A.C. Bréhin, I. Casadémont, M.P. Frenkiel, C. Julier, A. Sakuntabhai, and P. Desprès The large form of human 2′,5′-oligoadenylate synthetase (oas3) exerts antiviral effect against chikungunya virus Virology 384 1 2009 216 222
11. M. Chabaud, P. Garnero, J.M. Dayer, P.A. Guerne, F. Fossiez, and P. Miossec Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis Cytokine 12 7 2000 1092 1099
12. N.H. Chandak, R.S. Kashyap, D. Kabra, P. Karandikar, S.S. Saha, S.H. Morey, H.J. Purohit, G.M. Taori, and H.F. Daginawala Neurological complications of chikungunya virus infection Neurol. India 57 2 2009 177 180
13. L.J. Chang, K.A. Dowd, F.H. Mendoza, J.G. Saunders, S. Sitar, S.H. Plummer, G. Yamshchikov, U.N. Sarwar, Z. Hu, M.E. Enama, R.T. Bailer, R.A. Koup, R.M. Schwartz, W. Akahata, G.J. Nabel, J.R. Mascola, T.C. Pierson, B.S. Graham, J.E. Ledgerwood, and V.R.C.S. Team Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial Lancet 384 9959 2014 2046 2052
14. T. Chareonsirisuthigul, S. Kalayanarooj, and S. Ubol Dengue virus (denv) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-denv free radical and pro-inflammatory cytokine production, in thp-1 cells J. Gen. Virol. 88 2 2007 365 375
15. S. Chattopadhyay, A. Kumar, P. Mamidi, T.K. Nayak, I. Das, J. Chhatai, I. Basantray, U. Bramha, P.K. Maiti, S. Singh, A.R. Suryawanshi, and S. Chattopadhyay Development and characterization of monoclonal antibody against non-structural protein-2 of chikungunya virus and its application J. Virol. Methods 199 2014 86 94
16. C.I. Chen, D.C. Clark, P. Pesavento, N.W. Lerche, P.A. Luciw, W.K. Reisen, and A.C. Brault Comparative pathogenesis of epidemic and enzootic chikungunya viruses in a pregnant rhesus macaque model Am. J. Trop. Med. Hyg. 83 6 2010 1249 1258
17. W. Chen, S.S. Foo, N.E. Rulli, A. Taylor, K.C. Sheng, L.J. Herrero, B.L. Herring, B.A. Lidbury, R.W. Li, N.C. Walsh, N.A. Sims, P.N. Smith, and S. Mahalingam Arthritogenic alphaviral infection perturbs osteoblast function and triggers pathologic bone loss Proc. Natl. Acad. Sci. U. S. A. 111 16 2014 6040 6045
18. W. Chen, S.S. Foo, A. Taylor, A. Lulla, A. Merits, L. Hueston, M.R. Forwood, N.C. Walsh, N.A. Sims, L.J. Herrero, and S. Mahalingam Bindarit, an inhibitor of monocyte chemotactic protein synthesis, protects against bone loss induced by chikungunya virus infection J. Virol. 89 1 2015 581 593
19. A. Chow, Z. Her, E.K.S. Ong, J.M. Chen, F. Dimatatac, D.J.C. Kwek, T. Barkham, H. Yang, L. Rénia, Y.S. Leo, and L.F.P. Ng Persistent arthralgia induced by chikungunya virus infection is associated with interleukin-6 and granulocyte macrophage colony-stimulating factor J. Infect. Dis. 203 2 2011 149 157
20. C.L. Chua, Y.F. Chan, and I.C. Sam Characterisation of mouse monoclonal antibodies targeting linear epitopes on chikungunya virus e2 glycoprotein J. Virol. Methods 195 2014 126 133
21. G. Clavarino, N. Claudio, T. Couderc, A. Dalet, D. Judith, V. Camosseto, E.K. Schmidt, T. Wenger, M. Lecuit, E. Gatti, and P. Pierre Induction of GADD34 is necessary for dsRNA-dependent interferon-beta production and participates in the control of chikungunya virus infection PLoS Pathog. 8 5 2012 e1002708
22. M. Colonna, G. Trinchieri, and Y.J. Liu Plasmacytoid dendritic cells in immunity Nat. Immunol. 5 12 2004 1219 1226
23. T. Couderc, F. Chrétien, C. Schilte, O. Disson, M. Brigitte, F. Guivel-Benhassine, Y. Touret, G. Barau, N. Cayet, I. Schuffenecker, P. Desprès, F. Arenzana-Seisdedos, A. Michault, M.L. Albert, and M. Lecuit A mouse model for chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease PLoS Pathog. 4 2 2008 e29
24. T. Couderc, N. Khandoudi, M. Grandadam, C. Visse, N. Gangneux, S. Bagot, J.F. Prost, and M. Lecuit Prophylaxis and therapy for chikungunya virus infection J. Infect. Dis. 200 4 2009 516 523
25. T. Decker, S. Stockinger, M. Karaghiosoff, M. Muller, and P. Kovarik IFNS and stats in innate immunity to microorganisms J. Clin. Invest. 109 10 2002 1271 1277
26. T. Dhaeze, P. Stinissen, A. Liston, and N. Hellings Humoral autoimmunity: a failure of regulatory t cells? Autoimmun. Rev. 2015 10.1016/j.autrev.2015.04.006 [epub ahead of print]
27. A. Economopoulou, M. Dominguez, B. Helynck, D. Sissoko, O. Wichmann, P. Quenel, P. Germonneau, and I. Quatresous Atypical chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease during the 2005-2006 outbreak on reunion Epidemiol. Infect. 137 4 2009 534 541
28. J. Fessler, A. Felber, C. Duftner, and C. Dejaco Therapeutic potential of regulatory t cells in autoimmune disorders BioDrugs 27 4 2013 281 291
29. J. Fric, S. Bertin-Maghit, C.I. Wang, A. Nardin, and L. Warter Use of human monoclonal antibodies to treat chikungunya virus infection J. Infect. Dis. 207 2 2013 319 322
30. J.J. Fros, W.J. Liu, N.A. Prow, C. Geertsema, M. Ligtenberg, D.L. Vanlandingham, E. Schnettler, J.M. Vlak, A. Suhrbier, A.A. Khromykh, and G.P. Pijlman Chikungunya virus nonstructural protein 2 inhibits type I/II interferon-stimulated JAK-STAT signaling J. Virol. 84 20 2010 10877 10887
31. J. Gardner, I. Anraku, T.T. Le, T. Larcher, L. Major, P. Roques, W.A. Schroder, S. Higgs, and A. Suhrbier Chikungunya virus arthritis in adult wild-type mice J. Virol. 84 16 2010 8021 8032
32. D. Glick, S. Barth, and K.F. Macleod Autophagy: cellular and molecular mechanisms J. Pathol. 221 1 2010 3 12
33. L.Y. Goh, J. Hobson-Peters, N.A. Prow, J. Gardner, H. Bielefeldt-Ohmann, A.T. Pyke, A. Suhrbier, and R.A. Hall Neutralizing monoclonal antibodies to the e2 protein of chikungunya virus protects against disease in a mouse model Clin. Immunol. 149 3 2013 487 497
34. L.Y. Goh, J. Hobson-Peters, N.A. Prow, J. Gardner, H. Bielefeldt-Ohmann, A. Suhrbier, and R.A. Hall Monoclonal antibodies specific for the capsid protein of chikungunya virus suitable for multiple applications J. Gen. Virol. 96 3 2015 507 512
35. M.G. Guzman, and G. Kouri Dengue haemorrhagic fever integral hypothesis: confirming observations, 1987-2007 Trans. R. Soc. Trop. Med. Hyg. 102 6 2008 522 523
36. M.G. Guzman, G. Kouri, L. Valdes, J. Bravo, S. Vazquez, and S.B. Halstead Enhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 cuban outbreaks Rev. Panam. Salud Publica 11 4 2002 223 227
37. D. Hallengärd, F.M. Lum, B.M. Kümmerer, A. Lulla, V. Lulla, J. García-Arriaza, J.K. Fazakerley, P. Roques, R. le Grand, A. Merits, L.F.P. Ng, M. Esteban, and P. Liljeström Prime-boost immunization strategies against chikungunya virus J. Virol. 88 22 2014 13333 13343
38. S.B. Halstead Dengue antibody-dependent enhancement: knowns and unknowns Microbiol. Spec. 2 6 2014
39. Z. Her, Y.W. Kam, R.T.P. Lin, and L.F.P. Ng Chikungunya: a bending reality Microbes Infect. 11 14 2009 1165 1176
40. Z. Her, B. Malleret, M. Chan, E.K.S. Ong, S.C. Wong, D.J.C. Kwek, H. Tolou, R.T.P. Lin, P.A. Tambyah, L. Rénia, and L.F.P. Ng Active infection of human blood monocytes by chikungunya virus triggers an innate immune response J. Immunol. 184 10 2010 5903 5913
41. Z. Her, T.S. Teng, J.J. Tan, T.H. Teo, Y.W. Kam, F.M. Lum, W.W. Lee, C. Gabriel, R. Melchiotti, A.K. Andiappan, V. Lulla, A. Lulla, M.K. Win, A. Chow, S.K. Biswas, Y.S. Leo, M. Lecuit, A. Merits, L. Renia, and L.F. Ng Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus-specific neutralizing antibody response EMBO Mol. Med. 7 1 2015 24 41
42. L.J. Herrero, M. Nelson, A. Srikiatkhachorn, R. Gu, S. Anantapreecha, G. Fingerle-Rowson, R. Bucala, E. Morand, L.L. Santos, and S. Mahalingam Critical role for macrophage migration inhibitory factor (MIF) in Ross River virus-induced arthritis and myositis Proc. Natl. Acad. Sci. U. S. A. 108 29 2011 12048 12053
43. L.J. Herrero, K.C. Sheng, P. Jian, A. Taylor, Z. Her, B.L. Herring, A. Chow, Y.S. Leo, M.J. Hickey, E.F. Morand, L.F. Ng, R. Bucala, and S. Mahalingam Macrophage migration inhibitory factor receptor CD74 mediates alphavirus-induced arthritis and myositis in murine models of alphavirus infection Arthritis Rheum. 65 10 2013 2724 2736
44. J.J. Hoarau, M.C. Jaffar Bandjee, P. Krejbich Trotot, T. Das, G. Li-Pat-Yuen, B. Dassa, M. Denizot, E. Guichard, A. Ribera, T. Henni, F. Tallet, M.P. Moiton, B.A. Gauzère, S. Bruniquet, Z. Jaffar Bandjee, P. Morbidelli, G. Martigny, M. Jolivet, F. Gay, M. Grandadam, H. Tolou, V. Vieillard, P. Debré, B. Autran, and P. Gasque Persistent chronic inflammation and infection by chikungunya arthritogenic alphavirus in spite of a robust host immune response J. Immunol. 184 10 2010 5914 5927
45. L.C. Hofbauer, S. Khosla, C.R. Dunstan, D.L. Lacey, T.C. Spelsberg, and B.L. Riggs Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells Endocrinology 140 9 1999 4367 4370
46. K. Honda, A. Takaoka, and T. Taniguchi Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors Immunity 25 3 2006 349 360
47. C.A. Janeway Jr., and R. Medzhitov Innate immune recognition Annu. Rev. Immunol. 20 2002 197 216
48. P.H. Jones, M. Maric, M.N. Madison, W. Maury, R.J. Roller, and C.M. Okeoma BST-2/tetherin-mediated restriction of chikungunya (CHIKV) VLP budding is counteracted by CHIKV non-structural protein 1 (NSP1) Virology 438 1 2013 37 49
49. P.E. Joubert, S.W. Werneke, C. de la Calle, F. Guivel-Benhassine, A. Giodini, L. Peduto, B. Levin, O. Schwartz, D.J. Lenschow, and M.L. Albert Chikungunya virus-induced autophagy delays caspase-dependent cell death J. Exp. Med. 209 5 2012 1029 1047
50. D. Judith, S. Mostowy, M. Bourai, N. Gangneux, M. Lelek, M. Lucas-Hourani, N. Cayet, Y. Jacob, M.C. Prevost, P. Pierre, F. Tangy, C. Zimmer, P.O. Vidalain, T. Couderc, and M. Lecuit Species-specific impact of the autophagy machinery on chikungunya virus infection EMBO Rep. 14 6 2013 534 544
51. Y.W. Kam, W.W.L. Lee, D. Simarmata, S. Harjanto, T.S. Teng, H. Tolou, A. Chow, R.T.P. Lin, Y.-S. Leo, L. Rénia, and L.F.P. Ng Longitudinal analysis of the human antibody response to chikungunya virus infection: implications for sero-diagnosis assays and vaccine development J. Virol. 86 23 2012 13005 13015
52. Y.W. Kam, W.W.L. Lee, D. Simarmata, R. le Grand, H. Tolou, A. Merits, P. Roques, and L.F. Ng Unique epitopes recognized by antibodies induced in chikungunya virus-infected non-human primates: implications for the study of immunopathology and vaccine development PLoS One 9 4 2014 e95647
53. Y.W. Kam, F.M. Lum, T.H. Teo, W.W.L. Lee, D. Simarmata, S. Harjanto, C.L. Chua, Y.F. Chan, J.K. Wee, A. Chow, R.T.P. Lin, Y.S. Leo, R. le Grand, I.C. Sam, J.C. Tong, P. Roques, K.H. Wiesmüller, L. Rénia, O. Rötzschke, and L.F.P. Ng Early neutralizing igg response to chikungunya virus in infected patients targets a dominant linear epitope on the e2 glycoprotein EMBO Mol. Med. 4 4 2012 330 343
54. Y.W. Kam, E.K. Ong, L. Rénia, J.C. Tong, and L.F. Ng Immuno-biology of chikungunya and implications for disease intervention Microbes Infect. 11 14 2009 1186 1196
55. Y.W. Kam, D. Simarmata, A. Chow, Z. Her, T.S. Teng, E.K.S. Ong, L. Rénia, Y.S. Leo, and L.F.P. Ng Early appearance of neutralizing immunoglobulin g3 antibodies is associated with chikungunya virus clearance and long-term clinical protection J. Infect. Dis. 205 7 2012 1147 1154
56. Y.W. Kam, K.Y. Pok, K.E. Eng, L.K. Tan, S. Kaur, W.W.L. Lee, Y.S. Leo, L.C. Ng, and L.F. Ng Sero-prevalence and cross-reactivity of chikungunya virus specific anti-e2ep3 antibodies in arbovirus-infected patients PLoS Negl. Trop. Dis. 9 1 2015 e3445
57. R.S. Kashyap, S.H. Morey, N.H. Chandak, H.J. Purohit, G.M. Taori, and H.F. Daginawala Detection of viral antigen, IGM and IGG antibodies in cerebrospinal fluid of chikungunya patients with neurological complications Cerebrospinal Fluid Res. 7 2010 12
58. T. Kawai, and S. Akira The role of pattern-recognition receptors in innate immunity: update on toll-like receptors Nat. Immunol. 11 5 2010 373 384
59. T. Kawai, K. Takahashi, S. Sato, C. Coban, H. Kumar, H. Kato, K.J. Ishii, O. Takeuchi, and S. Akira IPS-1, an adaptor triggering RIG-I- and MDA5-mediated type I interferon induction Nat. Immunol. 6 10 2005 981 988
60. A.A. Kelvin, D. Banner, G. Silvi, M.L. Moro, N. Spataro, P. Gaibani, F. Cavrini, A. Pierro, G. Rossini, M.J. Cameron, J.F. Bermejo-Martin, S.G. Paquette, L. Xu, A. Danesh, A. Farooqui, I. Borghetto, D.J. Kelvin, V. Sambri, and S. Rubino Inflammatory cytokine expression is associated with chikungunya virus resolution and symptom severity PLoS Negl. Trop. Dis. 5 8 2011 e1279
61. S. Kotake, N. Udagawa, N. Takahashi, K. Matsuzaki, K. Itoh, S. Ishiyama, S. Saito, K. Inoue, N. Kamatani, M.T. Gillespie, T.J. Martin, and T. Suda IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis J. Clin. Invest. 103 9 1999 1345 1352
62. P. Krejbich-Trotot, M. Denizot, J.J. Hoarau, M.C. Jaffar-Bandjee, T. Das, and P. Gasque Chikungunya virus mobilizes the apoptotic machinery to invade host cell defenses FASEB J. 25 1 2011 314 325
63. P. Krejbich-Trotot, B. Gay, G. Li-Pat-yuen, J.J. Hoarau, M.C. Jaffar-Bandjee, L. Briant, P. Gasque, and M. Denizot Chikungunya triggers an autophagic process which promotes viral replication Virol. J. 8 1 2011 432
64. K.A. Kulcsar, V.K. Baxter, I.P. Greene, and D.E. Griffin Interleukin 10 modulation of pathogenic th17 cells during fatal alphavirus encephalomyelitis Proc. Natl. Acad. Sci. U. S. A. 111 45 2014 16053 16058
65. T.S. Kupper, and R.C. Fuhlbrigge Immune surveillance in the skin: mechanisms and clinical consequences Nat. Rev. Immunol. 4 3 2004 211 222
66. K. Labadie, T. Larcher, C. Joubert, A. Mannioui, B. Delache, P. Brochard, L. Guigand, L. Dubreil, P. Lebon, B. Verrier, X. de Lamballerie, A. Suhrbier, Y. Cherel, R. le Grand, and P. Roques Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages J. Clin. Invest. 120 3 2010 894 906
67. W.W.L. Lee, T.H. Teo, Z. Her, F.M. Lum, Y.W. Kam, D. Hasse, L. Rénia, O. Rötzschke, and L.F.P. Ng Expanding regulatory T cells alleviates chikungunya virus-induced pathology in mice J. Virol. 2015 10.1128/JVI.00998-15 [epub ahead of print]
68. J.Y.S. Leung, M.M.L. Ng, and J.J.H. Chu Replication of alphaviruses: a review on the entry process of alphaviruses into cells Adv. Virol. 2011 10.1155/2011/249640
69. Y. Li, C.M. Backesjo, L.A. Haldosen, and U. Lindgren IL-6 receptor expression and IL-6 effects change during osteoblast differentiation Cytokine 43 2 2008 165 173
70. B.A. Lidbury, N.E. Rulli, A. Suhrbier, P.N. Smith, S.R. McColl, A.L. Cunningham, A. Tarkowski, N. van Rooijen, R.J. Fraser, and S. Mahalingam Macrophage-derived proinflammatory factors contribute to the development of arthritis and myositis after infection with an arthrogenic alphavirus J. Infect. Dis. 197 11 2008 1585 1593
71. B.A. Lidbury, C. Simeonovic, G.E. Maxwell, I.D. Marshall, and A.J. Hapel Macrophage-induced muscle pathology results in morbidity and mortality for Ross River virus-infected mice J. Infect. Dis. 181 1 2000 27 34
72. K.M. Long, A.C. Whitmore, M.T. Ferris, G.D. Sempowski, C. McGee, B. Trollinger, B. Gunn, and M.T. Heise Dendritic cell immunoreceptor regulates chikungunya virus pathogenesis in mice J. Virol. 87 10 2013 5697 5706
73. K.M. Long, and M.T. Heise Protective and pathogenic responses to chikungunya virus infection Curr. Trop. Med. Rep. 2 2015 13 21
74. B. Lu, B.J. Rutledge, L. Gu, J. Fiorillo, N.W. Lukacs, S.L. Kunkel, R. North, C. Gerard, and B.J. Rollins Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice J. Exp. Med. 187 4 1998 601 608
75. F.M. Lum, T.H. Teo, W.W.L. Lee, Y.W. Kam, L. Rénia, and L.F.P. Ng An essential role of antibodies in the control of chikungunya virus infection J. Immunol. 190 12 2013 6295 6302
76. W.H. Lumsden An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53. II. General description and epidemiology Trans. R. Soc. Trop. Med. Hyg. 49 1 1955 33 57
77. P. Masrinoul, O. Puiprom, A. Tanaka, M. Kuwahara, P. Chaichana, K. Ikuta, P. Ramasoota, and T. Okabayashi Monoclonal antibody targeting chikungunya virus envelope 1 protein inhibits virus release Virology 464-465 2014 111 117
78. K.L. Mccance, and S.E. Huether Pathophysiology: The Biologic Basis for Disease in Adults and Children 2014 Elsevier Health Sciences
79. R. Medzhitov, and C. Janeway Innate immune recognition: mechanisms and pathways Immunol. Rev. 173 1 2000 89 97
80. J.V. Melton, G.D. Ewart, R.C. Weir, P.G. Board, E. Lee, and P.W. Gage Alphavirus 6K proteins form ion channels J. Biol. Chem. 277 49 2002 46923 46931
81. I. Messaoudi, J. Vomaske, T. Totonchy, C.N. Kreklywich, K. Haberthur, L. Springgay, J.D. Brien, M.S. Diamond, V.R. Defilippis, and D.N. Streblow Chikungunya virus infection results in higher and persistent viral replication in aged rhesus macaques due to defects in anti-viral immunity PLoS Negl. Trop. Dis. 7 7 2013 e2343
82. F. Meyer-Wentrup, D. Benitez-Ribas, P.J. Tacken, C.J. Punt, C.G. Figdor, I.J. de Vries, and G.J. Adema Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-alpha production Blood 111 8 2008 4245 4253
83. H.I. Nakaya, J. Gardner, Y.S. Poo, L. Major, B. Pulendran, and A. Suhrbier Gene profiling of chikungunya virus arthritis in a mouse model reveals significant overlap with rheumatoid arthritis Arthritis Rheum. 64 11 2012 3553 3563
84. J.K. Ng, S.L. Zhang, H.C. Tan, B. Yan, J.M. Martinez, W.Y. Tan, J.H. Lam, G.K. Tan, E.E. Ooi, and S. Alonso First experimental in vivo model of enhanced dengue disease severity through maternally acquired heterotypic dengue antibodies PLoS Pathog. 10 4 2014 e1004031
85. L.F.P. Ng, A. Chow, Y.-J. Sun, D.J.C. Kwek, P.-L. Lim, F. Dimatatac, L.-C. Ng, E.-E. Ooi, K.-H. Choo, Z. Her, P. Kourilsky, and Y.-S. Leo IL-1beta, IL-6, and rantes as biomarkers of chikungunya severity PLoS One 4 1 2009 e4261
86. M. Noret, L. Herrero, N. Rulli, M. Rolph, P.N. Smith, R.W. Li, P. Roques, G. Gras, and S. Mahalingam Interleukin 6, rankl, and osteoprotegerin expression by chikungunya virus-infected human osteoblasts J. Infect. Dis. 206 3 2012 455-457: 457-459
87. R.Y. Ong, F.M. Lum, and L.F. Ng The fine line between protection and pathology in neurotropic flavivirus and alphavirus infections Fut. Virol. 9 3 2014 313 330
88. J.S. Orange, and C.A. Biron An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections J. Immunol. 156 3 1996 1138 1142
89. S. Ozden, M. Huerre, J.P. Riviere, L.L. Coffey, P.V. Afonso, V. Mouly, J. de Monredon, J.C. Roger, M. el Amrani, and J.L. Yvin Human muscle satellite cells as targets of chikungunya virus infection PLoS One 2 6 2007 e527
90. P. Pal, K.A. Dowd, J.D. Brien, M.A. Edeling, S. Gorlatov, S. Johnson, I. Lee, W. Akahata, G.J. Nabel, M.K. Richter, J.M. Smit, D.H. Fremont, T.C. Pierson, M.T. Heise, and M.S. Diamond Development of a highly protective combination monoclonal antibody therapy against chikungunya virus PLoS Pathog. 9 4 2013 e1003312
91. M. Panning, K. Grywna, M. van Esbroeck, P. Emmerich, and C. Drosten Chikungunya fever in travelers returning to Europe from the Indian Ocean Region, 2006 Emerg. Infect. Dis. 14 3 2008 416 422
92. C.D. Partidos, J. Paykel, J. Weger, E.M. Borland, A.M. Powers, R. Seymour, S.C. Weaver, D.T. Stinchcomb, and J.E. Osorio Cross-protective immunity against O'nyong-Nyong virus afforded by a novel recombinant chikungunya vaccine Vaccine 30 31 2012 4638 4643
93. C. Petitdemange, P. Becquart, N. Wauquier, V. Béziat, P. Debré, E.M. Leroy, and V. Vieillard Unconventional repertoire profile is imprinted during acute chikungunya infection for natural killer cells polarization toward cytotoxicity PLoS Pathog. 7 9 2011 e1002268
94. Y.S. Poo, H. Nakaya, J. Gardner, T. Larcher, W.A. Schroder, T.T. Le, L.D. Major, and A. Suhrbier CCR2 deficiency promotes exacerbated chronic erosive neutrophil-dominated chikungunya virus arthritis J. Virol. 88 12 2014 6862 6872
95. Y.S. Poo, P.A. Rudd, J. Gardner, J.A. Wilson, T. Larcher, M.A. Colle, T.T. Le, H.I. Nakaya, D. Warrilow, R. Allcock, H. Bielefeldt-Ohmann, W.A. Schroder, A.A. Khromykh, J.A. Lopez, and A. Suhrbier Multiple immune factors are involved in controlling acute and chronic chikungunya virus infection PLoS Negl. Trop. Dis. 8 12 2014 e3354
96. K. Ramsauer, M. Schwameis, C. Firbas, M. Mullner, R.J. Putnak, S.J. Thomas, P. Despres, E. Tauber, B. Jilma, and F. Tangy Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial Lancet Infect. Dis. 15 5 2015 519 527
97. A.A. Rashad, S. Mahalingam, and P.A. Keller Chikungunya virus: emerging targets and new opportunities for medicinal chemistry J. Med. Chem. 57 4 2014 1147 1166
98. M. Romano, M. Sironi, C. Toniatti, N. Polentarutti, P. Fruscella, P. Ghezzi, R. Faggioni, W. Luini, V. van Hinsbergh, and S. Sozzani Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment Immunity 6 3 1997 315 325
99. P.A. Rudd, J. Wilson, J. Gardner, T. Larcher, C. Babarit, T.T. Le, I. Anraku, Y. Kumagai, Y.M. Loo, M. Gale Jr., S. Akira, A.A. Khromykh, and A. Suhrbier Interferon response factors 3 and 7 protect against chikungunya virus hemorrhagic fever and shock J. Virol. 86 18 2012 9888 9898
100. N.E. Rulli, M.S. Rolph, A. Srikiatkhachorn, S. Anantapreecha, A. Guglielmotti, and S. Mahalingam Protection from arthritis and myositis in a mouse model of acute chikungunya virus disease by bindarit, an inhibitor of monocyte chemotactic protein-1 synthesis J. Infect. Dis. 204 7 2011 1026 1030
101. B. Salvador, Y. Zhou, A. Michault, M.O. Muench, and G. Simmons Characterization of chikungunya pseudotyped viruses: identification of refractory cell lines and demonstration of cellular tropism differences mediated by mutations in e1 glycoprotein Virology 393 1 2009 33 41
102. C. Schilte, M.R. Buckwalter, M.E. Laird, M.S. Diamond, O. Schwartz, and M.L. Albert Cutting edge: independent roles for IRF-3 and IRF-7 in hematopoietic and nonhematopoietic cells during host response to chikungunya infection J. Immunol. 188 7 2012 2967 2971
103. C. Schilte, T. Couderc, F. Chretien, M. Sourisseau, N. Gangneux, F. Guivel-Benhassine, A. Kraxner, J. Tschopp, S. Higgs, A. Michault, F. Arenzana-Seisdedos, M. Colonna, L. Peduto, O. Schwartz, M. Lecuit, and M.L. Albert Type I IFN controls chikungunya virus via its action on nonhematopoietic cells J. Exp. Med. 207 2 2010 429 442
104. J.W. Schoggins, and C.M. Rice Interferon-stimulated genes and their antiviral effector functions Curr. Opin. Virol. 1 6 2011 519 525
105. J.W. Schoggins, S.J. Wilson, M. Panis, M.Y. Murphy, C.T. Jones, P. Bieniasz, and C.M. Rice A diverse range of gene products are effectors of the type I interferon antiviral response Nature 472 7344 2011 481 485
106. O. Schwartz, and M.L. Albert Biology and pathogenesis of chikungunya virus Nat. Rev. Microbiol. 8 7 2010 491 500
107. S. Selvarajah, N.R. Sexton, K.M. Kahle, R.H. Fong, K.A. Mattia, J. Gardner, K. Lu, N.M. Liss, B. Salvador, D.F. Tucker, T. Barnes, M. Mabila, X. Zhou, G. Rossini, J.B. Rucker, D.A. Sanders, A. Suhrbier, V. Sambri, A. Michault, M.O. Muench, B.J. Doranz, and G. Simmons A neutralizing monoclonal antibody targeting the acid-sensitive region in chikungunya virus e2 protects from disease PLoS Negl. Trop. Dis. 7 9 2013 e2423
108. L.D. Shultz, F. Ishikawa, and D.L. Greiner Humanized mice in translational biomedical research Nat. Rev. Immunol. 7 2 2007 118 130
109. F.P. Siegal, N. Kadowaki, M. Shodell, P.A. Fitzgerald-Bocarsly, K. Shah, S. Ho, S. Antonenko, and Y.-J. Liu The nature of the principal type 1 interferon-producing cells in human blood Science 284 5421 1999 1835 1837
110. A.J. Snyder, and S. Mukhopadhyay The alphavirus e3 glycoprotein functions in a clade-specific manner J. Virol. 86 24 2012 13609 13620
111. M. Soden, H. Vasudevan, B. Roberts, R. Coelen, G. Hamlin, S. Vasudevan, and J. la Brooy Detection of viral ribonucleic acid and histologic analysis of inflamed synovium in Ross River virus infection Arthritis Rheum. 43 2 2000 365 369
112. M. Solignat, B. Gay, S. Higgs, L. Briant, and C. Devaux Replication cycle of chikungunya: a re-emerging arbovirus Virology 393 2 2009 183 197
113. M. Sourisseau, C. Schilte, N. Casartelli, C. Trouillet, F. Guivel-Benhassine, D. Rudnicka, N. Sol-Foulon, K. le Roux, M.C. Prevost, H. Fsihi, M.P. Frenkiel, F. Blanchet, P.V. Afonso, P.E. Ceccaldi, S. Ozden, A. Gessain, I. Schuffenecker, B. Verhasselt, A. Zamborlini, A. Saib, F.A. Rey, F. Arenzana-Seisdedos, P. Despres, A. Michault, M.L. Albert, and O. Schwartz Characterization of reemerging chikungunya virus PLoS Pathog. 3 6 2007 e89
114. K.A. Stapleford, L.L. Coffey, S. Lay, A.V. Borderia, V. Duong, O. Isakov, K. Rozen-Gagnon, C. Arias-Goeta, H. Blanc, S. Beaucourt, T. Haliloglu, C. Schmitt, I. Bonne, N. Ben-Tal, N. Shomron, A.B. Failloux, P. Buchy, and M. Vignuzzi Emergence and transmission of arbovirus evolutionary intermediates with epidemic potential Cell Host Microbe 15 6 2014 706 716
115. D.B. Stetson, and R. Medzhitov Type I interferons in host defense Immunity 25 3 2006 373 381
116. J.H. Strauss, and E.G. Strauss The alphaviruses: gene expression, replication, and evolution Microbiol. Rev. 58 3 1994 491 562
117. A. Takada, and Y. Kawaoka Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications Rev. Med. Virol. 13 6 2003 387 398
118. A. Taylor, K.C. Sheng, L.J. Herrero, W. Chen, N.E. Rulli, and S. Mahalingam Methotrexate treatment causes early onset of disease in a mouse model of Ross River virus-induced inflammatory disease through increased monocyte production PLoS One 8 8 2013 e71146
119. K. Taylor, O. Kolokoltsova, M. Patterson, A. Poussard, J. Smith, D.M. Estes, and S. Paessler Natural killer cell mediated pathogenesis determines outcome of central nervous system infection with Venezuelan equine encephalitis virus in C3H/HEN mice Vaccine 30 27 2012 4095 4105
120. T.S. Teng, S.S. Foo, D. Simamarta, F.M. Lum, T.H. Teo, A. Lulla, N.K.W. Yeo, E.G.L. Koh, A. Chow, Y.S. Leo, A. Merits, K.C. Chin, and L.F.P. Ng Viperin restricts chikungunya virus replication and pathology J. Clin. Invest. 122 12 2012 4447 4460
121. T.S. Teng, Y.W. Kam, J.J. Tan, and L.F.P. Ng Host response to chikungunya virus and perspectives for immune-based therapies Fut. Virol. 6 8 2011 975 984
122. T.S. Teng, Y.W. Kam, B. Lee, H.C. Hapuarachchi, A. Wimal, L.C. Ng, and L.F.P. Ng A systematic meta-analysis of immune signatures in patients with acute chikungunya virus infection J. Infect. Dis. 2015 10.1093/infdis/jiv049 [epub ahead of print]
123. T.H. Teo, Z. Her, J.J.L. Tan, F.M. Lum, W.W.L. Lee, Y.H. Chan, R.Y. Ong, Y.W. Kam, I. Leparc-Goffart, P. Gallian, L. Rénia, X. Delamballerie, and L.F.P. Ng Caribbean and la réunion chikungunya virus isolates differ in their capacity to induce pro-inflammatory Th1 and NK cell responses and acute joint pathology J. Virol. 2015 10.1128/JVI.00909-15 [epub ahead of print]
124. T.H. Teo, F.M. Lum, C. Claser, V. Lulla, A. Lulla, A. Merits, L. Rénia, and L.F.P. Ng A pathogenic role for CD4+ T cells during chikungunya virus infection in mice J. Immunol. 190 1 2013 259 269
125. O. Uchime, W. Fields, and M. Kielian The role of e3 in ph protection during alphavirus assembly and exit J. Virol. 87 18 2013 10255 10262
126. J.E. Voss, M.-C. Vaney, S. Duquerroy, C. Vonrhein, C. Girard-Blanc, E. Crublet, A. Thompson, G. Bricogne, and F.A. Rey Glycoprotein organization of chikungunya virus particles revealed by X-ray crystallography Nature 468 7324 2010 709 712
127. L. Warter, C.Y. Lee, R. Thiagarajan, M. Grandadam, S. Lebecque, R.T. Lin, S. Bertin-Maghit, L.F. Ng, J.P. Abastado, P. Despres, C.I. Wang, and A. Nardin Chikungunya virus envelope-specific human monoclonal antibodies with broad neutralization potency J. Immunol. 186 5 2011 3258 3264
128. V. Watanaveeradej, T.P. Endy, S. Simasathien, A. Kerdpanich, N. Polprasert, C. Aree, D.W. Vaughn, and A. Nisalak Transplacental chikungunya virus antibody kinetics, Thailand Emerg. Infect. Dis. 12 11 2006 1770 1772
129. N. Wauquier, P. Becquart, D. Nkoghe, C. Padilla, A. Ndjoyi-Mbiguino, and E.M. Leroy The acute phase of chikungunya virus infection in humans is associated with strong innate immunity and T CD8 cell activation J. Infect. Dis. 204 1 2011 115 123
130. S.W. Werneke, C. Schilte, A. Rohatgi, K.J. Monte, A. Michault, F. Arenzana-Seisdedos, D.L. Vanlandingham, S. Higgs, A. Fontanet, M.L. Albert, and D.J. Lenschow ISG15 is critical in the control of chikungunya virus infection independent of UBE1L mediated conjugation PLoS Pathog. 7 10 2011 e1002322
131. L.K. White, T. Sali, D. Alvarado, E. Gatti, P. Pierre, D. Streblow, and V.R. Defilippis Chikungunya virus induces ips-1-dependent innate immune activation and protein kinase r-independent translational shutoff J. Virol. 85 1 2011 606 620
132. N. Wikan, P. Sakoonwatanyoo, S. Ubol, S. Yoksan, and D.R. Smith Chikungunya virus infection of cell lines: analysis of the east, central and South African lineage PLoS One 7 1 2012 e31102
133. N.E. Yun, B.H. Peng, A.S. Bertke, V. Borisevich, J.K. Smith, J.N. Smith, A.L. Poussard, M. Salazar, B.M. Judy, M.A. Zacks, D.M. Estes, and S. Paessler Cd4+ t cells provide protection against acute lethal encephalitis caused by Venezuelan equine encephalitis virus Vaccine 27 30 2009 4064 4073
134. R.M. Zellweger, T.R. Prestwood, and S. Shresta Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease Cell Host Microbe 7 2 2010 128 139
135. Y. Zhang, W.D. Shlomchik, G. Joe, J.-P. Louboutin, J. Zhu, A. Rivera, D. Giannola, and S.G. Emerson APCS in the liver and spleen recruit activated allogeneic CD8+ T cells to elicit hepatic graft-versus-host disease J. Immunol. 169 12 2002 7111 7118